Just weeks away from the launch of Pamela Glasner’s novel “Finding Emmaus” and one of the book’s underlying themes is being echoed in reality.
The historic fantasy is also a meticulously researched commentary on the “treatment” of people deemed to be mentally ill, especially the effect on real people of efforts by Big Pharma to sell more drugs.
Enjoy this short video on “Finding Emmaus” and read below how in REALITY, Big Pharma gets busted for using Ghost writers to lobby lawmakers considering crucial health reforms in the US.
From the nytimes.com By NATASHA SINGER
Published: August 4, 2009
Newly unveiled court documents show that ghostwriters paid by a pharmaceutical company played a major role in producing 26 scientific papers backing the use of hormone replacement therapy in women, suggesting that the level of hidden industry influence on medical literature is broader than previously known.
Meanwhile, the use of anti-depressants has doubled in a decade in the USA, while the number of people seeking psychiatric treatment is falling.
A study quoted in the USA Today article below suggests that doctors with little or no up to date specialist knowledge are increasingly writing scripts for SSRI and other heavily promoted drugs.
Any specialist will tell you that even at their best the SSRI and other medications are at best only a bandaid, and far too often lead to suicidal ideation, especially in the first two weeks of use.
Many advocacy groups are now being heard in their pleas for balanced, consumer informed resources to be made available at all doctors rooms, everywhere.
Related articles by Zemanta
- Buddhists May Help Biotechies Solve Big Mental Health Woes, Says Merck Vet Ben Shapiro (xconomy.com)
- Tamoxifen and Antidepressants Don’t Mix (health.usnews.com)
- Antidepressant failed to help autistic children, caused side-effects: study (cbc.ca)
- New study reveals that antidepressants are not created equal (nationalpost.com)
- The myth of the chemical cure and the lie of serotonin imbalance (seroxatsecrets.wordpress.com)